Neuroimmunomodulatory actions of hypothalamic interferon-α

NeuroImmunoModulation

Volumn 5, Issue 3-4, 1998, Pages 172-177

  Hori, Tetsuro ^a   Katafuchi, Toshihiko ^a   Take, Sachiko ^a   Shimizu, Nobuaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing factor; Hypothalamus; Interferon ; Natural killer cytotoxicity; NMDA responses; Opioid receptors; Spleen; Sympathetic nerve

Indexed keywords

ALPHA INTERFERON; BETA ADRENERGIC RECEPTOR; BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; N METHYL DEXTRO ASPARTIC ACID; NALOXONE; NITRIC OXIDE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PROSTANOID; REACTIVE OXYGEN METABOLITE; RECOMBINANT ALPHA INTERFERON;

ANALGESIA; ANOREXIA; CELL INTERACTION; DRUG EFFECT; DRUG RECEPTOR BINDING; FEEDBACK SYSTEM; FEVER; GLIA CELL; HUMAN; HYPOTHALAMUS; IMMUNOMODULATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MEDIAL PREOPTIC AREA; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN CELL; SYMPATHETIC NERVE; ZONA INCERTA;

ANIMALS; HUMANS; HYPOTHALAMUS; INTERFERON-ALPHA; NEUROIMMUNOMODULATION;

EID: 0031666487     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026334     Document Type: Review

References (63)

1. Pestka S, Langar JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 1987;56:727-777.
2. Tovey MG, Streuli M, Gresser I, Gugenheim J, Blanchard B, Guymarho J, Vignaux F, Gigou M: Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci USA 1987;34:5038-5042.
3. Lebon P, Girard S, Thepot F, Chany C: The presence of alpha-interferon in human amniotic fluid. J Gen Virol 1982;59:393-396.
4. Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, Katafuchi T: Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 1991;27: 309-313.
5. Smedley H, Katrak M, Sikora K, Wheeler T: Neurological effects of recombinant human interferon. Br Med J 1983;286:262-264.
6. Habif DV, Lipton L, Cantell K: Interferon crosses blood-cerebrospinal fluid barrier in monkeys. Proc Soc Exp Biol Med 1975;149: 287-289.
7. Pan W, Banks WA, Kastin AJ: Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol 1997;76:105-111.
8. Marcovistz R, Tsiang H, Hovanessian AG: Production and action of interferon in mice infected with rabies virus. Ann Inst Pasteur Paris 1984;135E:19-33.
9. Lloyd A, Hickie I, Brockman A, Dwyer J, Wakefield D: Cytokines levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis 1991;164:1023-1024.
10. von Sydow M, Sonnenborg A, Gaines H, Strannegard O: Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:375-380.
11. Tedeschi B, Barret JN, Keane RW: Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J Cell Biol 1986;102:2244-2253.
12. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989;86:6348-6352.
13. Janicki PK: Binding of human alpha-interferon in the brain tissue membranes of the rat. Res Commun Chem Pathol Pharmacol 1992;75: 117-120.
14. Ho-Yen DO, Carrington D: Alpha-interferon responses in cerebrospinal fluid of patients with suspected meningitis. J Clin Pathol 1987; 40:83-86.
15. Brandt ER, Mackay IR, Hertzog PJ, Cheetham BA, Sherritt M, Bernard CC: Molecular detection of interferon-a expression in multiple sclerosis brain. J Neuroimmunol 1993;44:1-6.
16. Yamada T, Yamanaka I: Microglial localization of α-interferon receptor in human brain tissues. Neurosci Lett 1995;189:73-76.
17. Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL: Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 1994;50:195-201.
18. Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T: Immunohistochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci Lett 1994;181: 61-64.
19. Gupta SL, Raziuddin A, Sarkar FH: Receptors for human alpha interferon: Are gangliosides involved? J Interferon Res 1984;4:305-314.
20. Borgeson M, Tallent MW, Keane RW: Astrocyte modulation of central nervous system immune responses; in Goetzl EJ, Spector NH (eds): Neuroimmune Networks: Physiology and Diseases. New York, Alan R. Liss, 1989, pp 51-55.
21. Dinarello CA, Bernheim HA, Duff GW, Le HV, Nagabhshan TL, Hamilton NC, Coceani C: Mechanisms of fever induced by recombinant human interferon. J Clin Invest 1984;74: 906-913.
22. Nakashima T, Murakami T, Murai Y, Hori T, Miyata S, Kiyohara T: Naloxone suppresses the rising phase of fever induced by interferon-α. Brain Res Bull 1995;37:61-66.
23. Plata-Salaman CR: Interferons and central regulation of feeding. Am J Physiol 1992;263: R1222-R1227.
24. Krueger JM, Toth LA, Floyd R, Fang J, Kapas L, Bredow S, Obal F: Sleep, microbes and cytokines. Neuroimmunomodulation 1994;1:100-109.
25. Nakamura H, Nakanishi K, Kita A, Kadokawa T: Interleukin-1 induces analgesia in mice by a central action. Eur J Pharmacol 1988;149:49-54.
26. Blalock JE, Smith EM: Human leukocyte interferon (HuIFN-α): Potent endorphin-like opioid activity. Biochem Biophys Res Commun 1981; 101:472-478.
27. Take S, Mori T, Katafuchi T, Hori T: Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am J Physiol 1993;265:R453-R459.
28. Katafuchi T, Take S, Hori T: Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol (Lond) 1993;465:343-357.
29. Saphier D, Roerig SC, Ito C, Vlasak WR, Farrar GE, Broyles JE, Welch JE: Inhibition of neural and neuroendocrine activity by α-interferon: Neuroendocrine, electrophysiological, and biochemical studies in the rat. Brain Behav Immun 1994;8:37-56.
30. Calvet MC, Gresser MC: Interferon enhances the excitability of cultured neurones. Nature 1979;278:558-560.
31. Dafny N, Prieto-Gomez B, Reyes-Vazquez C: Does the immune system communicate with the central nervous system? Interferon modifies central nervous activity. J Neuroimmunol 1985;9:1-12.
32. Nakashima T, Hori T, Kuriyama K, Matsuda T: Effects of interferon-a on the activity of preoptic thermosensitive neurons in tissue slices. Brain Res 1988;454:361-367.
33. Kuriyama K, Hori T, Mori T, Nakashima T: Actions of interferon-α and interleukin-1β on the glucose-responsive neurons in the ventromedial hypothalamus. Brain Res Bull 1990;24: 803-810.
34. Mueller M, Fontana A, Zbinden G, Gaehwiler BH: Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 1993;619:157-162.
35. Cathala F, Baron S: Interferon in rabbit brain, cerebrospinal fluid and serum following administration of polyinosinic-polycytidylic acid. J Immunol 1970;104:1355-1358.
36. Menzies RA, Patel R, Hall NRS, O'Grady MP, Rier SE: Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes. Life Sci 1992;50:227-232.
37. Shavit Y, Terman GW, Martin FC, Lewis JW, Liebeskind JC, Gale RP: Stress, opioid peptides, the immune system, and cancer. J Immunol 1985;135:834S-837S.
38. Mori T, Kaizuka Y, Hori T, Nakashima T: Effects of intracerebral injection of β-endorphin on the cytotoxic activity of natural killer cells in the spleen. Jpn J Physiol 1989;39: S118.
39. Take S, Mori T, Katafuchi T, Kaizuka Y, Hori T: Central interferon-α suppresses the cytotoxic activity of natural killer cells in the mouse spleen. Ann NY Acad Sci 1992;650:46-50.
40. Take S, Uchimura D, Kanemitsu Y, Katafuchi T, Hori T: Interferon-α acts at the preoptic hypothalamus to reduce natural killer cytotoxicity in rats. Am J Physiol 1995;268:R1406-R1410.
41. Dunn AJ, Berridge CW: Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990;15:71-100.
42. Buckingham JC: Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 1982;35:111-116.
43. Bellinger DL, Felten SY, Lorton D, Felten DL: Origin of noradrenergic innervation of the spleen in rats. Brain Behav Immun 1989;3: 291-311.
44. Katafuchi T, Ichijo T, Take S, Hori T: Hypothalamic modulation of natural killer cell activity in rats. J Physiol (Lond) 1993;471:209-221.
45. Irwin M, Hauger RL, Brown M, Britton KT: CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol 1988;255:R744-R747.
46. Ichijo T, Katafuchi T, Hori T: Central interleukin-1β enhances splenic sympathetic nerve activity in rats. Brain Res Bull 1994;34:547-553.
47. Swanson LW: An autoradiographic study of the efferent connections of the preoptic region in the rat. J Comp Neurol 1976;167:227-256.
48. Saphier D, Feldman S: Effects of stimulation of the preoptic area on hypothalamic paraventricular nucleus unit activity and corticosterone secretion in freely moving rats. Neuroendocrinology 1986;42:167-173.
49. Shimizu N, Hori T, Nakane H: An interleukin-1β-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: An in vivo microdialysis study in conscious rats. Brain Behav Immun 1994;7:14-23.
50. Shimizu N, Kaizuka Y, Hori T, Nakane H: Immobilization increases norepinephrine release and reduces NK cytotoxicity in spleen of conscious rat. Am J Physiol 1996;271:R537-R544.
51. Katafuchi T, Take S, Hori T: Roles of cytokines in the neural-immune interactions: Modulation of NMDA responses by IFN-α. Neurobiology 1995;3:319-327.
52. Parton MJ, Gayton RJ, Taylor DCM: The effect of glutamate receptor antagonists on rat thermoreactive hypothalamic neurones. J Physiol (Lond) 1991;438:78P.
53. Chen L, Huang LYM: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ-opioid. Neuron 1970;7:319-326.
54. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992;356: 521-523.
55. Snell LD, Iorio KR, Tabakoff B, Hoffman PL: Protein kinase C activation attenuates N-methyl-D-aspartate-induced increases in intracellular calcium in cerebellar granule cells. J Neurochem 1994;62:1783-1789.
56. Chen X, Gillis CN: Effect of free radicals on pulmonary vascular response to acetylcholine. J Appl Physiol 1991;71:821-825.
57. Floyd RA, Henderson R, Watson JJ, Wong PK: Use of salicylate with high pressure liquid chromatography and electrochemical detection as a sensitive measure of hydroxyl free radicals in adriamycin treated rats. J Free Radical Biol Med 1986;2:13-18.
58. Aizenman E: Modulation of N-methyl-D-aspartate receptors by hydroxyl radicals in rat cortical neurons in vitro. Neurosci Lett 1995; 189:57-59.
59. Piani D, Spranger M, Frei K, Schaffner A, Fontana A: Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992;22:2429-2436.
60. Lei SZ, Pan ZH, Aggarwal SK, Chen HSV, Hartman J, Sucher NJ, Lipton SA: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992;8:1087-1099.
61. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992;281:419-424.
62. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz DJ: Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993;16:323-328.
63. Zhang X, Alley EW, Russell SW, Morrison DC: Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect Immun 1994;62:33-40.